Showing 221-230 of 4186 results for "".
Staphylococcus aureus and Atopic Dermatitis: Unweaving a Tangled Web
https://practicaldermatology.com/topics/general-topics/staphylococcus-aureus-and-atopic-dermatitis-unweaving-a-tangled-web/22083/Though the relationship is not fully understood, it points the way to potential treatments.FDA Warns on Expression; Lilly's Ixekizumab Data Promising
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-warns-on-expression-lilly-s-ixekizumab-data-promising/19093/Lilly's Ixekizumab phase III data look good for psoriasis, and the FDA warns on improper use of Expression hyaluronic acid as a dermal filler. Plus, Sitavig is available for herpes labialis, and Syneron's laser gets an onychomycosis clearance.Skin Cancer Prevention Through Photoprotection: What Your Patients Should Know
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-prevention-through-photoprotection-what-your-patients-should-know/26540/Skin Cancer Prevention Through Photoprotection: What Your Patients Should KnowNitric Oxide-Releasing Cleanser for Plantar Warts
https://practicaldermatology.com/topics/clinical-case-reports/nitric-oxide-releasing-cleanser-plantar-warts/27121/The authors present a case study of a 12-year-old girl developed a few small warts on the plantar surface of both feet, and over a 6-month period.From SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FDermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-counterfeit-botox-cases-widen-new-hs-treatment-approved-europe/24419/In this episode of DermwireTV, the use of counterfeit Botox continues to widen; a first-of-its-kind drug is approved in Europe for hidradenitis suppurativa; and the PA Perspective series provides tips for training and onboarding in a new practice.DermWireTV: Skyrizi for PsA; Toxins and Wound Healing at Maui Derm; SDDS Registration
https://practicaldermatology.com/topics/psoriasis/skyrizi-for-psa-toxins-and-wound-healing-at-maui-derm-sdds-registration-dermwiretv/20057/Skyrizi (AbbVie) is now approved for the treatment of adults with active psoriatic arthritis. Michael Gold, MD was among the speakers who offered updates on cosmetic trends as well as medical care at Maui Dermatology for Dermatologists last week. He spoke about high-dose neurotoxins. Robert KirsnerQuarantine Quorum: Circling the Wagons
https://practicaldermatology.com/topics/practice-management/quarantine-quorum-circling-the-wagons/18180/With Quarantine Quorum, host Neal Bahtia, MD provides a diary of life during the COVID-19 pandemic, talking to members of the dermatology community as they adapt to ongoing changes in their personal and private lives. In this edition, Hilary Baldwin, MD; Adam J. Friedman, MD; Mark Kaufmann, MD; andEnd Game: Why You Need Long-term Goals and an Exit Plan
https://practicaldermatology.com/topics/practice-management/end-game-why-you-need-long-term-goals-and-an-exit-plan/23217/Establishing long-term goals helps you make smart hiring and firing decisions along the way.Sexual Wellness is a Dermatologic Legacy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sexual-wellness-is-a-dermatologic-legacy/20315/It should come as no surprise that dermatologists are applying energy-based devices to support sexual health and wellness. The specialty's legacy is rooted in sexual health.